Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bubendorf

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Journal of the National Cancer Institute|August 3, 2000
Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysisM Bärlund, F Forozan, J Kononen, et al.
Cancer Immunology, Immunotherapy : CII|August 9, 2020
Chemotherapy negatively impacts the tumor immune microenvironment in NSCLC: an analysis of pre- and post-treatment biopsies in the multi-center SAKK19/09 studyM A Amrein, E D Bührer, M L Amrein, et al.
Journal of the National Cancer Institute|August 2, 2001
Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancerR Simon, A Nocito, T Hübscher, et al.
Virchows Archiv : an International Journal of Pathology|October 2, 2014
Incidental prostate cancer prevalence at radical cystoprostatectomy--importance of the histopathological work-upC Wetterauer, M Weibel, J R Gsponer, et al.
Cancer Research|November 21, 2000
Loss of NKX3.1 expression in human prostate cancers correlates with tumor progressionC Bowen, L Bubendorf, H J Voeller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2007
Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03G D'Addario, D Rauch, R Stupp, et al.
BJU International|February 28, 2004
Consistency of prostate cancer grading results in screened populations across EuropeT H Van der Kwast, M J Roobol, M F Wildhagen, et al.
Prostate Cancer and Prostatic Diseases|January 29, 2014
ERG rearrangement and protein expression in the progression to castration-resistant prostate cancerJ R Gsponer, M Braun, V J Scheble, et al.
Journal of the National Cancer Institute|October 21, 1999
Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarraysL Bubendorf, M Kolmer, J Kononen, et al.
Infection|July 18, 2012
Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantationA Egli, C Bucher, A Dumoulin, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Journal of the National Cancer Institute|August 3, 2000
Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysisM Bärlund, F Forozan, J Kononen, et al.
Cancer Immunology, Immunotherapy : CII|August 9, 2020
Chemotherapy negatively impacts the tumor immune microenvironment in NSCLC: an analysis of pre- and post-treatment biopsies in the multi-center SAKK19/09 studyM A Amrein, E D Bührer, M L Amrein, et al.
Journal of the National Cancer Institute|August 2, 2001
Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancerR Simon, A Nocito, T Hübscher, et al.
Virchows Archiv : an International Journal of Pathology|October 2, 2014
Incidental prostate cancer prevalence at radical cystoprostatectomy--importance of the histopathological work-upC Wetterauer, M Weibel, J R Gsponer, et al.
Cancer Research|November 21, 2000
Loss of NKX3.1 expression in human prostate cancers correlates with tumor progressionC Bowen, L Bubendorf, H J Voeller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2007
Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03G D'Addario, D Rauch, R Stupp, et al.
BJU International|February 28, 2004
Consistency of prostate cancer grading results in screened populations across EuropeT H Van der Kwast, M J Roobol, M F Wildhagen, et al.
Prostate Cancer and Prostatic Diseases|January 29, 2014
ERG rearrangement and protein expression in the progression to castration-resistant prostate cancerJ R Gsponer, M Braun, V J Scheble, et al.
Journal of the National Cancer Institute|October 21, 1999
Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarraysL Bubendorf, M Kolmer, J Kononen, et al.
Infection|July 18, 2012
Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantationA Egli, C Bucher, A Dumoulin, et al.
Pageof 9